Atlas Global Brands Inc.
Atlas Global Brands Inc. engages in the production, distribution, and sale of cannabis in Canada, Australia, Germany, Israel, Denmark, Norway, Spain, and the United Kingdom. It is involved in cannabis cultivation, manufacturing, marketing, distribution, and pharmacy activities, as well as provision of cannabis for the adult recreational market. The company offers its products under the D*gg Lbs, … Read more
Atlas Global Brands Inc. (AGBIF) - Net Assets
Latest net assets as of December 2023: $10.11 Million USD
Based on the latest financial reports, Atlas Global Brands Inc. (AGBIF) has net assets worth $10.11 Million USD as of December 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($65.24 Million) and total liabilities ($55.13 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $10.11 Million |
| % of Total Assets | 15.5% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Atlas Global Brands Inc. - Net Assets Trend (None–None)
This chart illustrates how Atlas Global Brands Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Atlas Global Brands Inc. (None–None)
The table below shows the annual net assets of Atlas Global Brands Inc. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Atlas Global Brands Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Atlas Global Brands Inc. Competitors by Market Cap
The table below lists competitors of Atlas Global Brands Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
HAGA S/A Indústria e Comércio
SA:HAGA3
|
$2.62 Million |
|
Pixium Vision SA
PINK:PXMVF
|
$2.62 Million |
|
Project Planning Service Public Company Limited
BK:PPS
|
$2.62 Million |
|
Supergas Energy Ltd
TA:SPGE
|
$2.62 Million |
|
Elecster Oyj A
HE:ELEAV
|
$2.61 Million |
|
M4B SA ZY 8
F:24D
|
$2.61 Million |
|
Indo Oil Perkasa PT
JK:OILS
|
$2.61 Million |
|
Storebrand Global Multifactor A5
CO:STIGM
|
$2.61 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Atlas Global Brands Inc.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Atlas Global Brands Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Atlas Global Brands Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Atlas Global Brands Inc.'s net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Atlas Global Brands Inc. (AGBIF) | $10.11 Million | N/A | 5.45x | $2.61 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |